Polypeptide APIs Product LIST
Alarelin Acetate Angiotensin Acetate Argipressin Acetate Atosiban Acetate Trifluoro Acetate Cetrorelix Acetate Deslorelin Acetate Desmopressin Acetate Elcatonin Acetate Enfuvirtide Acetate Eptifibatide Acetate Exenatide Acetate GLP-1(7-36)
THE BEST POLYPEPTIDE APIs COMPANY
ABOUT THE COMPANY
Chengdu Shengnuo Biotechnology Co., Ltd., established in July 2001, is located in Dayi County, Chengdu City, with a registered capital of 60 million yuan. Its wholly-owned subsidiary is Chengdu shengnuo biopharmaceutical Co., Ltd. From the initial registered capital of 1 million, to the current total assets of 250 million, the company has achieved sound and rapid development. With “Chengdu polypeptide drug engineering technology research center”, sinobio has passed the FDA certification of the United States, and has become a professional polypeptide drug and product development, technology transfer, technical services, large-scale production and export of peptide medicine industrial park.
What Makes Us Different?
One-stop Polypeptide Synthesis
We try our best to provide “One-Stop Peptide Searching Center”, in order to offer the best products and services for customers all around the world.
polypeptide production Service
Most frequent questions and answers
We do have Written confirmation (EU62) for the European market and other regions for some products ,it can replace the GMP certificate in some areas.
Yes, we have been inspected by US-FDA three times .We also have been inspected by KFDA and COFEPRIS.
We have the full and strong GMP quality system , accept the cFDA inspected from time to time .
We have the inner and outer quality verify system.
Annual customer’s Audit
- Good news! shengnuo biotechnology-Octreotide Acetate Injection won the bid in the national centralized drug procurement
- CStone Pharmaceuticals completes the first patient enrollment in Phase I clinical trials in the United States for the treatment of advanced B-cell lymphoma and solid tumors
- shengnuo biotechnology: Fertility drug “Atosiban Acetate Injection” passed the consistency evaluation of generic drugs
- shengnuo biotechnology: Subsidiary Octreotide Acetate API was certified by the European Medicines Agency
- eptifibatide injection
- somatostatin for injection
- shengnuobiotechnology has been investigated by 3 institutions: the peptide API segment is the company’s key development segment. This business has grown rapidly in the past two years. After the completion of the capacity expansion, it is expected to bring further profit growth to the company.
- peptide api manufacturing peptide company peptide manufacturer peptide medicine peptide order peptide preparation peptide product peptide production peptide services
- Good news! shengnuo Bio-Octreotide Acetate Injection won the bid in the national centralized drug procurement!
- Under the adverse economic environment,shengnuo biotechnology one-year growth interview and broadcast article listed on the Science and Technology Innovation Board
has passed the FDA certification of the United States, and has become a professional polypeptide drug and product development, technology transfer, technical services, large-scale production and export of peptide medicine industrial park.